Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Inflammatory Bowel Diseases
|
October 22, 2019
Mucosal Eosinophilia Is an Independent Predictor of Vedolizumab Efficacy in Inflammatory Bowel Diseases
Erin M Kim, Cara Randall, Renee Betancourt, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 8, 2020
A Model Using Clinical and Endoscopic Characteristics Identifies Patients at Risk for Eosinophilic Esophagitis According to Updated Diagnostic Guidelines
Cary C Cotton, Renee Betancourt, Cara Randall, et al.
Digestive Diseases and Sciences
|
January 25, 2021
Generic Measures of Quality of Life Are Not Correlated with Disease Activity in Eosinophilic Esophagitis
Nicole Chang, Soha Raja, Renee Betancourt, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 15, 2018
Clinical and Molecular Factors Associated With Histologic Response to Topical Steroid Treatment in Patients With Eosinophilic Esophagitis
Swathi Eluri, Sara R Selitsky, Irina Perjar, et al.
Plos One
|
September 1, 2022
Comparison of baseline lymphoma and HIV characteristics in Malawi before and after implementation of universal antiretroviral therapy
Yolanda Gondwe, Evaristar Kudowa, Tamiwe Tomoka, et al.
Cancer Medicine
|
November 30, 2019
High pretreatment plasma Epstein-Barr virus (EBV) DNA level is a poor prognostic marker in HIV-associated, EBV-negative diffuse large B-cell lymphoma in Malawi
Nathan D Montgomery, Cara Randall, Matthew Painschab, et al.
The Lancet. Global Health
|
May 22, 2021
Safety and efficacy of rituximab in patients with diffuse large B-cell lymphoma in Malawi: a prospective, single-arm, non-randomised phase 1/2 clinical trial
Stephen Kimani, Matthew S Painschab, Bongani Kaimila, et al.
Cancer Medicine
|
November 10, 2019
Modified EPOCH for high-risk non-Hodgkin lymphoma in sub-Saharan Africa
Takondwa Zuze, Grace K Ellis, Edwards Kasonkanji, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Inflammatory Bowel Diseases
|
October 22, 2019
Mucosal Eosinophilia Is an Independent Predictor of Vedolizumab Efficacy in Inflammatory Bowel Diseases
Erin M Kim, Cara Randall, Renee Betancourt, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 8, 2020
A Model Using Clinical and Endoscopic Characteristics Identifies Patients at Risk for Eosinophilic Esophagitis According to Updated Diagnostic Guidelines
Cary C Cotton, Renee Betancourt, Cara Randall, et al.
Digestive Diseases and Sciences
|
January 25, 2021
Generic Measures of Quality of Life Are Not Correlated with Disease Activity in Eosinophilic Esophagitis
Nicole Chang, Soha Raja, Renee Betancourt, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 15, 2018
Clinical and Molecular Factors Associated With Histologic Response to Topical Steroid Treatment in Patients With Eosinophilic Esophagitis
Swathi Eluri, Sara R Selitsky, Irina Perjar, et al.
Plos One
|
September 1, 2022
Comparison of baseline lymphoma and HIV characteristics in Malawi before and after implementation of universal antiretroviral therapy
Yolanda Gondwe, Evaristar Kudowa, Tamiwe Tomoka, et al.
Cancer Medicine
|
November 30, 2019
High pretreatment plasma Epstein-Barr virus (EBV) DNA level is a poor prognostic marker in HIV-associated, EBV-negative diffuse large B-cell lymphoma in Malawi
Nathan D Montgomery, Cara Randall, Matthew Painschab, et al.
The Lancet. Global Health
|
May 22, 2021
Safety and efficacy of rituximab in patients with diffuse large B-cell lymphoma in Malawi: a prospective, single-arm, non-randomised phase 1/2 clinical trial
Stephen Kimani, Matthew S Painschab, Bongani Kaimila, et al.
Cancer Medicine
|
November 10, 2019
Modified EPOCH for high-risk non-Hodgkin lymphoma in sub-Saharan Africa
Takondwa Zuze, Grace K Ellis, Edwards Kasonkanji, et al.
Page
of 2